Winds of Recovery, Scans of Growth - Wigton and IPCL Lift Quarterly Earnings

Stronger revenues lifted quarterly earnings at Wigton Energy Limited (WIG) and Image Plus Consultants Limited (IPCL); however, there was divergence in their half-year performances. WIG’s net profit increased 51.8% year-over-year (YoY) to J$144.63Mn for the quarter ended September 30, 2026, supported by higher electricity sales and lower finance costs. Meanwhile, IPCL’s profit climbed 185.7% to J$26.75Mn for the quarter ended August 31, 2026, reflecting growth in its existing operations and the first full quarter of contributions from Island Radiology Limited (IR).
WIG's revenues growth strengthened its core profitability. Quarterly sales increased 42.6% to J$726.55Mn, supported by higher electricity production, which outpaced a 21.0% increase in cost of sales. Consequently, gross profit rose 61.6% to J$438.66Mn. However, other income (-65.1%) and higher general administrative expenses (+28.8%) owing to repairs and maintenance following consecutive hurricanes in 2024 and 2025, continued investment in digitisation and inflationary pressures limited operating profit growth to 8.1% bringing it to J$227.97Mn. Debt repayments provided further relief, with finance expenses falling 49.7% to J$38.01Mn, supplemented by a return to profitability from its associate.
The quarterly rebound narrowed WIG’s half-year earnings shortfall. Net profit for the six months ended September 30 (H1) declined 11.5% to J$313.62Mn, following a 34.8% contraction in the first quarter. Electricity production increased 16.6% to 94.72 million kWh in H1, supported by favourable winds and plant maintenance, helping sales rise 13.6% to J$1.51Bn. Nevertheless, lower insurance proceeds and foreign exchange gains reduced other income, while hurricane-related repairs and materials pushed cost of sales up 21.1%, weighing on the overall result.
For IPCL, its expanded operations translated into higher scan volumes and stronger operating earnings. Quarterly revenues increased 70.9% to J$442.13Mn as scan volumes rose 57.4% to 20,635. Direct costs grew faster than revenues, narrowing the gross profit margin to 63.7% from 68.1%. However, administrative expenses - including J$15.60Mn in one-time acquisition costs, grew more slowly than revenues. This helped operating profit more than double to J$42.69Mn, absorbing higher depreciation and a 58.7% increase in finance costs associated primarily with acquisition financing. Overall, the half-year net profit rose 157.4% to J$59.45Mn on revenue growth of 50.9% to J$794.06Mn. Net margin widened to 7.5% from 4.4%, indicating that the expanded business converted a greater share of revenue into earnings.
Both companies have opportunities to extend earnings growth, with execution central to the outlook. WIG is advancing its 70.53 MW utility-scale solar project, pursuing regional opportunities and nearing the contracting stage for a major commercial and industrial solar project. These initiatives could diversify revenues beyond its single asset operation, although funding, delivery timelines and weather exposure remain key considerations. Meanwhile, IPCL’s expanded geographic reach following the Island Radiology acquisition, alongside its planned relocation to 33 Lady Musgrave Road before FY2027 ends, provides scope for further growth. Converting that scale into sustained profit growth will depend on successful integration, cost control and managing its higher debt burden.
At October 15, WIG closed at J$1.04, down 19.4% year-to-date, but traded at 63.80x earnings versus the Main Market Energy, Materials and Industrials sector median of 21.43x. Its quarterly recovery will therefore need to translate into more sustained earnings improvement to support that premium. IPCL, on the other hand, gained 76.0% to J$1.76 and traded at 25.14x earnings, slightly below the Junior Market Health sector median of 25.26x. Continued earnings growth and successful integration will be important to sustaining investor confidence following the rally.

(Sources: JSE & NCBCM Research)